Five Arrows Growth Capital, a private equity investment firm, completed the investment in BioPhorum, an operator of a cross-industry collaboration platform for the biopharmaceutical industry. Vespa Capital exited the investment. Financial terms were not disclosed. Under the ownership of Five Arrows, we expect BioPhorum will continue to cement its position in supply chain, operations and manufacturing collaboration, whilst looking to further expand its reach within the biopharmaceutical industry. The BioPhorum founders and management chose to partner with FAGC due to the Five Arrows track record of scaling and internationalising businesses combined with our global healthcare reach.